Rotator Cuff Articles & Analysis
19 news found
Some of the most common athletic injuries that regenerative therapy injections can cure include: ACL tears, tennis elbow, rotator cuff injuries, osteoarthritis, and damaged achilles tendons. ...
The company, headquartered in Milan, Italy, currently has several assets under development, such as vascular graft, bone graft substitutes, rotator cuff repair, drug release. ...
ByKLISBio
The company, headquartered in Milan, Italy, currently has several assets under development, such as vascular graft, bone graft substitutes, rotator cuff repair, drug release. ...
ByKLISBio
The company, headquartered in Milan, Italy, currently has several assets under development, such as vascular graft, bone graft substitutes, rotator cuff repair, drug release. ...
ByKLISBio
The company, headquartered in Milan, Italy, currently has several assets under development, such as vascular graft, bone graft substitutes, rotator cuff repair, drug release. ...
ByKLISBio
The company, headquartered in Milan, Italy, currently has several assets under development, such as vascular graft, bone graft substitutes, rotator cuff repair, drug release. ...
ByKLISBio
The company, headquartered in Milan, Italy, currently has several assets under development, such as vascular graft, bone graft substitutes, rotator cuff repair, drug release. ...
ByKLISBio
Building on the insights obtained from years of research studying regenerative cells, InGeneron is currently conducting three actively enrolling FDA-approved clinical trials. to evaluate its cell therapy platform for the treatment of musculoskeletal indications such as partial-thickness rotator cuff tear, wrist osteoarthritis, and facet joint syndrome. ...
The company is also working on silk technologies focused on vascular grafting, rotator cuff repair, bone grafting and drug release which they plan to launch between now and 2028. ...
ByKLISBio
The company, headquartered in Milan, Italy, currently has several assets under development, such as vascular graft, bone graft substitutes, rotator cuff repair, drug release. ...
ByKLISBio
The company, headquartered in Milan, Italy, currently has several assets under development, such as vascular graft, bone graft substitutes, rotator cuff repair, drug release. ...
ByKLISBio
InGeneron, Inc., a clinical stage biotechnology company, today announced that the American Medical Association’s (AMA) Current Procedural Terminology (CPT®) Editorial Panel has issued two new Category III CPT® codes for the company’s autologous, adipose-derived regenerative cell (ADRC) therapy for partial thickness rotator cuff tears. The ...
” Building on the insights obtained from years of research studying vaPS cells, InGeneron is currently conducting three actively enrolling FDA-approved clinical trials to evaluate its cell therapy platform for the treatment of musculoskeletal indications such as partial thickness rotator cuff tear, wrist osteoarthritis, and facet joint syndrome. About the ...
Jeff was also a key member of the Rotation Medical team, where he orchestrated the generation of post-market clinical data that drove market adoption for their regenerative implant for rotator cuff repair leading to a successful acquisition and transition to Smith & ...
” This clinical case report highlights the disease-modifying potential of InGeneron’s cell therapy for the treatment of symptomatic, partial-thickness rotator cuff tears, one of the most prevalent shoulder disorders in adults. ...
“David was also a key member of Rotation Medical, where he drove market adoption and clinical education of their regenerative implant for rotator cuff repair, from the first surgical case post-FDA clearance through a successful acquisition by Smith & ...
InGeneron, Inc., a regenerative medicine and cell therapy company, announced today the enrollment of the first patients in a pivotal study evaluating InGeneron’s cell therapy as a way to treat partial thickness rotator cuff tears involving a partial tear in the supraspinatus tendon. ...
The cured, hardened implant provides longitudinal strength and rotational stability over the length of the implant, stabilizing the fracture. ...
Once cured, the implant provides longitudinal strength and rotational stability over the length of the implant. The IlluminOss implant was developed as an alternative to currently used nails and plates, with the potential to provide better patient experiences and outcomes. ...